UK markets open in 7 hours 17 minutes
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.32 -0.06 (-0.08%) GOLD FUTURES
2,323.60 -0.60 (-0.03%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
49,991.96 -552.36 (-1.09%)
Avidity Biosciences, Inc. (RNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.33 |
| Open | 26.74 |
| Bid | 25.35 x 200 |
| Ask | 25.42 x 200 |
| Day's range | 24.96 - 26.74 |
| 52-week range | 4.82 - 27.66 |
| Volume | |
| Avg. volume | 1,165,690 |
| Market cap | 2.428B |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares
President and CEO Sarah Boyce of Avidity Biosciences Inc (NASDAQ:RNA) sold 28,000 shares of the company on April 2, 2024, according to a recent SEC filing.
- GuruFocus.com
Insider Sell: CFO Michael Maclean Sells 40,000 Shares of Avidity Biosciences Inc (RNA)
Michael Maclean, Chief Financial Officer of Avidity Biosciences Inc (NASDAQ:RNA), sold 40,000 shares of the company on March 13, 2024, according to a recent SEC filing.
- Investor's Business Daily
Top 2% Biotech Avidity Tumbles Despite 'Positive' Results In Treating Muscular Dystrophy
Top-notch biotech stock Avidity tumbled Monday despite unveiling "positive" midstage test results for its muscular dystrophy treatment.
© 2024 Yahoo. All rights reserved.